Domov › Delodajalci › Editas Medicine, Inc.
Editas Medicine, Inc.: Plače H-1B in sponzorstvo
Editas Medicine, Inc. je vložil 31 vlog za delovne pogoje za vizume H-1B in sorodne vizume v davčnih letih 2023–2026; potrjeno: 29. Median ponujene plače: $110.000.
Ali Editas Medicine, Inc. sponzorira vizume H-1B?
Editas Medicine, Inc. je vložil 31 vlog za delovne pogoje v davčnih letih 2023–2026, zadnja je bila oddana 4. jun. 2026. LCA je prvi korak prošnje za H-1B, zato je delodajalec sponzoriral ali se pripravil na sponzorstvo delavcev H-1B; to ne zagotavlja sponzorstva za določeno delovno mesto. Preverite lastne oglase za zaposlitev delodajalca.
Vloge za zeleno kartico (PERM) pri Editas Medicine, Inc.: 6 →
Plače po nazivih delovnih mest
| Naziv delovnega mesta | LCA | Mediana plače |
|---|---|---|
| Associate Scientist II, Cell Biology [00064810] | 2 | $111.238 |
| Senior QA Document Control Specialist [00061075] | 2 | $116.896 |
| Associate Scientist II, Cell Biology | 1 | $110.000 |
| Associate Process Engineer [00049798] | 1 | $86.549 |
| Senior Manager, Biophysical, Analytical Development | 1 | $151.525 |
| Principal Validation Engineer [00055448] | 1 | $94.141 |
| Manager, Regulatory Affairs [00055232] | 1 | $140.000 |
| Senior Downstream Process Development Manager [00058916] | 1 | $131.123 |
| Cell Manufacturing Associate [00051451] | 1 | $71.490 |
| Senior Specialist - Validation Engineer [00065107] | 1 | $127.858 |
| Principal Oracle Fusion Architect [00064327] | 1 | $157.643 |
| Principal Validation Engineer [00064027] | 1 | $127.858 |
| Associate Scientist I: LNP Delivery Technology [00062912] | 1 | $91.374 |
| Associate Scientist I [00062911] | 1 | $91.374 |
| Associate Scientist II [00066688] | 1 | $111.238 |
| Senior Manager, QA Technical Operations [00068130] | 1 | $150.000 |
| Manufacturing Associate [00063520] | 1 | $71.490 |
| Scientist II, Molecular Biology and Gene Editing [00065014] | 1 | $131.123 |
| Associate Scientist II [00071900] | 1 | $105.331 |
| Associate Scientist I, Next Generation Sequencing [00071409] | 1 | $100.000 |
| Senior Quality Control Analyst, Raw Materials and Testing | 1 | $87.797 |
| Quality Assurance Supervisor [00068703] | 1 | $116.896 |
| Process Engineer - Formulation [00073790] | 1 | $105.331 |
| Associate Scientist 1 [00080414] | 1 | $112.000 |
| Bioinformatics Analyst [00084550] | 1 | $85.842 |
| Associate Scientist 1 [00080415] | 1 | $102.000 |
| Associate Scientist 1 [00080412] | 1 | $102.200 |
| Associate Scientist, Delivery Technology [00109010] | 1 | $95.000 |
| Scientist I, Assay Development in vitro/in vivo Pharmacology | 1 | $134.971 |
Vloge po davčnih letih
| Poslovno leto | LCA | Mediana plače |
|---|---|---|
| Fy2023 | 5 | $110.000 |
| Fy2024 | 19 | $111.238 |
| Fy2025 | 5 | $102.200 |
| Fy2026 | 2 | $114.986 |
Stopnje prevladujočih plač
- Stopnja I (začetna)6 %
- Stopnja II (kvalificirana)45 %
- Stopnja III (izkušena)19 %
- Stopnja IV (polno usposobljena)29 %
Department of Labor določi štiri stopnje prevladujočih plač za vsak poklic in območje, od Stopnje I (začetna) do Stopnje IV (popolna usposobljenost). Delodajalec izbere stopnjo, ki ustreza zahtevam delovnega mesta.
Kje so delovna mesta
Poklici
- Molecular and Cellular Biologists22
- Industrial Engineers4
- Industrial Production Managers3
- Regulatory Affairs Specialists1
- Software Developers1
Najnovejše vloge
| Naziv delovnega mesta | Osnovna plača | Lokacija | Oddano | Datum začetka | Status |
|---|---|---|---|---|---|
| Scientist I, Assay Development in vitro/in vivo Pharmacology | $134.971–$145.000 Stopnja IV | Cambridge, MA | 4. jun. 2026 | 13. jul. 2026 | Certificirano |
| Associate Scientist, Delivery Technology [00109010] | $95.000–$125.000 Stopnja II | Cambridge, MA | 15. apr. 2026 | 1. okt. 2026 | Certificirano |
| Bioinformatics Analyst [00084550] | $85.842–$110.000 Stopnja II | Cambridge, MA | 17. apr. 2025 | 1. okt. 2025 | Certificirano |
| Associate Scientist 1 [00080412] | $102.200–$107.200 Stopnja II | Cambridge, MA | 9. apr. 2025 | 1. okt. 2025 | Certificirano |
| Associate Scientist 1 [00080415] | $102.000–$105.000 Stopnja II | Cambridge, MA | 9. apr. 2025 | 1. okt. 2025 | Certificirano |
| Associate Scientist 1 [00080414] | $112.000–$115.000 Stopnja II | Cambridge, MA | 24. mar. 2025 | 1. sep. 2025 | Certificirano |
| Process Engineer - Formulation [00073790] | $105.331–$135.000 Stopnja III | Cambridge, MA | 16. okt. 2024 | 4. nov. 2024 | Certificirano |
| Associate Scientist II [00071900] | $105.331–$115.000 Stopnja III | Cambridge, MA | 16. sep. 2024 | 7. okt. 2024 | Certificirano |
| Associate Scientist I, Next Generation Sequencing [00071409] | $100.000–$105.000 Stopnja II | Cambridge, MA | 14. avg. 2024 | 26. avg. 2024 | Certificirano |
| Senior Quality Control Analyst, Raw Materials and Testing | $87.797–$105.000 Stopnja II | Cambridge, MA | 23. jul. 2024 | 15. nov. 2024 | Certificirano |
| Quality Assurance Supervisor [00068703] | $116.896–$145.000 Stopnja II | Cambridge, MA | 25. jun. 2024 | 1. jul. 2024 | Certificirano |
| Associate Scientist I: LNP Delivery Technology [00062912] | $91.374–$105.000 Stopnja II | Cambridge, MA | 11. jun. 2024 | 1. okt. 2024 | Certificirano |
| Associate Scientist I [00062911] | $91.374–$105.000 Stopnja II | Cambridge, MA | 5. jun. 2024 | 1. okt. 2024 | Certificirano |
| Associate Scientist II [00066688] | $111.238–$125.000 Stopnja III | Cambridge, MA | 23. maj 2024 | 4. okt. 2024 | Certificirano |
| Senior Manager, QA Technical Operations [00068130] | $150.000–$180.000 Stopnja IV | Cambridge, MA | 8. maj 2024 | 20. maj 2024 | Certificirano |
| Scientist II, Molecular Biology and Gene Editing [00065014] | $131.123–$150.000 Stopnja IV | Cambridge, MA | 24. apr. 2024 | 1. okt. 2024 | Certificirano |
| Manufacturing Associate [00063520] | $71.490–$90.000 Stopnja I | Cambridge, MA | 24. apr. 2024 | 1. okt. 2024 | Certificirano |
| Senior Specialist - Validation Engineer [00065107] | $127.858–$135.000 Stopnja IV | Cambridge, MA | 19. mar. 2024 | 1. apr. 2024 | Certificirano |
| Associate Scientist II, Cell Biology [00064810] | $111.238–$135.000 Stopnja III | Cambridge, MA | 19. mar. 2024 | 12. sep. 2024 | Certificirano |
| Associate Scientist II, Cell Biology [00064810] | $111.238–$135.000 Stopnja III | Cambridge, MA | 18. mar. 2024 | 12. sep. 2024 | Umaknjeno |
| Principal Oracle Fusion Architect [00064327] | $157.643–$200.000 Stopnja IV | Cambridge, MA | 6. mar. 2024 | 18. mar. 2024 | Certificirano |
| Senior QA Document Control Specialist [00061075] | $116.896–$135.000 Stopnja II | Cambridge, MA | 14. feb. 2024 | 19. jul. 2024 | Certificirano |
| Senior QA Document Control Specialist [00061075] | $116.896–$135.000 Stopnja II | Cambridge, MA | 14. feb. 2024 | 19. jul. 2024 | Umaknjeno |
| Principal Validation Engineer [00064027] | $127.858–$140.000 Stopnja IV | Cambridge, MA | 14. feb. 2024 | 4. mar. 2024 | Certificirano |
| Senior Downstream Process Development Manager [00058916] | $131.123–$160.000 Stopnja IV | Cambridge, MA | 7. nov. 2023 | 3. maj 2024 | Certificirano |
| Cell Manufacturing Associate [00051451] | $71.490–$80.000 Stopnja I | Cambridge, MA | 25. sep. 2023 | 1. okt. 2023 | Certificirano |
| Principal Validation Engineer [00055448] | $94.141–$105.000 Stopnja II | Cambridge, MA | 12. jul. 2023 | 24. jul. 2023 | Certificirano |
| Manager, Regulatory Affairs [00055232] | $140.000–$150.000 Stopnja IV | Cambridge, MA | 27. jun. 2023 | 10. jul. 2023 | Certificirano |
| Associate Process Engineer [00049798] | $86.549–$115.000 Stopnja II | Cambridge, MA | 20. mar. 2023 | 16. avg. 2023 | Certificirano |
| Senior Manager, Biophysical, Analytical Development | $151.525–$160.000 Stopnja IV | Cambridge, MA | 23. feb. 2023 | 10. avg. 2023 | Certificirano |
| Associate Scientist II, Cell Biology | $110.000–$120.000 Stopnja III | Cambridge, MA | 2. nov. 2022 | 14. nov. 2022 | Certificirano |
Plače so spodnja meja ponujene plače pri vsaki vlogi, pretvorjene v letni znesek; statistika uporablja samo potrjene vloge za polni delovni čas. LCA ni odobritev vizuma, ena LCA pa lahko pokriva več delovnih mest. Vir: U.S. Department of Labor, OFLC LCA Disclosure Data, davčna leta 2023–2026 (najnovejša odločitev 30. jun. 2026).